The 2011 dengue haemorrhagic fever outbreak in lahore - an account of clinical parameters and pattern of haemorrhagic complications

Journal of the College of Physicians and Surgeons Pakistan

Volumn 23, Issue 7, 2013, Pages 463-467

  Ahmed, Shahid ^a   Mohammad, Wasim Wali ^a   Hamid, Faran ^a   Akhter, Amim ^a   Afzal, Raja Kamran ^a   Mahmood, Asif ^a  

^a Malir National University of Medical Sciences   (Pakistan)

Author keywords

Dengue fever (DF); Dengue haemorrhagic fever (DHF); Dengue shock syndrome (DSS); Haemorrhagic complications

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN; CREATININE; POTASSIUM; SODIUM; UREA;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASCITES; BILIRUBIN BLOOD LEVEL; BLOOD CELL COUNT; BLOOD CLOTTING DISORDER; BLOOD SAMPLING; BRAIN HEMORRHAGE; CLINICAL EVALUATION; CLINICAL FEATURE; CLINICAL PROTOCOL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DENGUE; DESCRIPTIVE RESEARCH; DISEASE SEVERITY; EPIDEMIC; EPISTAXIS; FEMALE; GINGIVA BLEEDING; HEMATEMESIS; HEMATURIA; HEMOPTYSIS; HEMORRHAGIC FEVER; HOSPITALIZATION; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MELENA; MORTALITY; NEUROLOGIC DISEASE; ORAL BLEEDING; OUTCOME ASSESSMENT; PAKISTAN; PALLIATIVE THERAPY; POTASSIUM BLOOD LEVEL; PRACTICE GUIDELINE; PROTHROMBIN TIME; PUBLIC HOSPITAL; PURPURIC RASH; RECTUM HEMORRHAGE; SEROLOGY; SODIUM BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; THROMBOCYTOPENIA; UREA BLOOD LEVEL; VOMITING; WORLD HEALTH ORGANIZATION;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALANINE TRANSAMINASE; BILIRUBIN; DISEASE OUTBREAKS; FEMALE; FEVER; HUMANS; MALE; MIDDLE AGED; PAKISTAN; REGRESSION ANALYSIS; SEVERE DENGUE; SEVERITY OF ILLNESS INDEX; THROMBOCYTOPENIA; URBAN POPULATION; VOMITING; YOUNG ADULT;

EID: 84880760402     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Kroeger A, Nathan M, Hombach J, World Health Organization TDR Reference Group on dengue. Dengue Nat Rev Microbiol 2004; 2:360-1.
2. Teixeira MG, Barreto ML. Diagnosis and management of dengue. BMJ 2009; 339:b4338.
3. Deen JL, Harris E, Wills B, Balmaseda A, Hammond SN, Rocha C, et al. The WHO dengue classification and case definitions: time for a reassessment. Lancet 2006; 368:170-3.
4. Balmaseda A, Hammond SN, Pérez L, Tellez Y, Saborío SI, Mercado JC, et al. Serotype specific differences in clinical manifestations of dengue. Am J Trop Med Hyg 2006; 74: 449-56.
5. Fried JR, Gibbons RV, Kalayanarooj S, Thomas SJ, Srikiatkhachorn A, Thomas SJ, et al. Serotype-specific differences in the risk of dengue haemorrhagic fever: an analysis of data collected in Bangkok, Thailand from 1994 to 2006. PLoS neglected tropical diseases 2010; 4:e617.
6. Chan YC, Salahuddin NI, Khan J, Tan HC, Seah CL, Li J, et al. Dengue haemorrhagic fever outbreak in Karachi, Pakistan, 1994. Trans R Soc Trop Med Hyg 1995; 89:619-20.
7. Ahmed S, Ali N, Ashraf S, Ilyas M, Tariq WU, Chotani RA. Dengue fever outbreak: a clinical management experience. J Coll Physicians Surg Pak 2008; 18:8-12.
8. WHO. Dengue haemorrhagic fever: diagnosis, treatment, prevention, and control. Geneva: World Health Organization; 1997.
9. Rigau-Pérez JG, Laufer MK. Dengue-related deaths in Puerto Rico, 1992-1996: diagnosis and clinical alarm signals. Clin Infect Dis 2006; 42:1241-6. Epub 2006 Mar 21.
10. World Health Organization. Dengue: guidelines for diagnosis, treatment, prevention and control. Geneva: World Health Organization; 2009.
11. Cameron P, Simmons, Jeremy J, Chau NV, Wills B. Dengue, current concepts. N Engl J Med 2012; 366:1423-32.
12. Teixeira MG, Costa Mda C, Barreto F, Barreto ML. Dengue: twenty five years since re-emergence in Brazil. Cad Saude Publica 2009; 1:S7-18.
13. Guzmán MG, Kourí G. Dengue: an update. Lancet Infect Dis 2002; 2:33-42.
14. World Health Organization. Dengue and dengue haemorrhagic fever: fact sheet. No. 117 [Internet]. 2002. Available from: http://www.who.int/mediacentre/factsheets/fs117/en/
15. Rasul CH, Ahasan HA, Rasid AK, Khan MR. Epidemiological factors of dengue haemorrhagic fever in Bangladesh. Indian Pediatr 2002; 39:369-72.
16. Bhaskar EM, Moorthy ES, Kumar NS, Arthur P. Dengue haemorrhagic fever in adults: an observational study in Chennai, South India. Indian J Med Res 2010; 132:738-40.
17. Fatima Z, Idrees M, Bajwa MA, Tahir Z, Obaidullah, Zia MQ, et al. Serotype and genotype analysis of dengue virus by sequencing followed by phylogenetic analysis using samples from three mini-outbreaks-2007-2009 in Pakistan. BMC Microbiol 2011; 10:200.
18. Mahmood N, Rana MY, Qureshi Z, Mujtaba G, Shaukat U. Prevalence and molecular characterization of dengue viruses serotypes in 2010 epidemic. Am J Med Sci 2012; 343:61-4.
19. Humayoun MA, Waseem T, Jawa AA, Hashmi MS, Akram J. Multiple dengue serotypes and high frequency of dengue haemorrhagic fever at two tertiary care hospitals in Lahore during the 2008 dengue virus outbreak in Punjab, Pakistan. Int J Infect Dis 2010; 14:e54-9. Epub 2010 Feb 19.
20. Balmaseda A, Mercado JC, Matute JC, Tellez Y, Saborío S. Trends in patterns of dengue transmission in a pediatric cohort study in Nicaragua. J Infect Dis 2001; 201:5-14.
21. Guilarde AO, Turchi MD, Siqueira JB Jr., Feres VC, Rocha B, Levi JE, et al. Dengue and dengue haemorrhagic fever among adults: clinical outcomes related to viremia, serotypes, and antibody response. J Infect Dis 2008; 197:817-24.
22. Swaminathan S, Khanna N. Dengue: recent advances in biology and current status of translational research. Curr Mol Med 2009; 9:152-73.
23. Webster DP, Farrar J, Rowland-Jones S. Progress towards a dengue vaccine. Lancet Infect Dis 2009; 9:678-87.